Screening for cytomegalovirus retinitis in children

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 11, 1996, Pages 1186-1192

  Baumal, Caroline R ^a,c   Levin, Alex V ^a,b   Kavalec, Conrad C ^a,b   Petric, Martin ^a,b   Khan, Hamza ^a   Read, Stanley E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMBINED IMMUNODEFICIENCY; CYTOMEGALOVIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINITIS; SCREENING TEST; VIRUS CULTURE; VIRUS ISOLATION;

EID: 0029855595     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170360076013     Document Type: Article

References (64)

1. Alford CA, Stagno S, Pass RF, Huang ES. Epidemiology of cytomegalovirus. In: Nahmias AJ, Dowdle WR, Schinazi RF, eds. The Human Herpesviruses. New York, NY: Elsevier Science Inc; 1981:159-171.
2. Stagno S, Pass RF, Dworsky ME, Alford CA. Congenital and perinatal cytomegalovirus infections. Semin Perinatol. 1983;7:31-42.
3. Alford CA, Stagno S, Pass RF, Britt WJ. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis. 1990;12(suppl 7):S745-S753.
4. Weller TH. Clinical spectrum of cytomegalovirus infection. In: Nahmias AJ, Dowdle WR, Schinazi RF, eds. The Human Herpesviruses. New York, NY: Elsevier Science Inc; 1981:20-30.
5. Becroft DM. Prenatal cytomegalovirus infection: epidemiology, pathology and pathogenesis. Perspect Pediatr Pathol. 1981;6:203-241.
6. Drew WL. Diagnosis of cytomegalovirus infection. Rev Infect Dis. 1988;10 (suppl 3):S468-S476.
7. Drew WL. Cytomegalovirus infection in patients with AIDS. J Infect Dis. 1988; 158:449-456.
8. Grundy JE. Virologic and pathogenic aspects of cytomegalovirus infection. Rev Infect Dis. 1990;12(suppl 7):S711-S719.
9. Hennis HL, Scott AA, Apple DJ. Cytomegalovirus retinitis. Surv Ophthalmol. 1989;34:193-203.
10. Rook AH. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis. 1988;10(suppl 3):S460-S467.
11. Porter R, Crombie AL, Gardner PS, Uldall RP. Incidence of ocular complications in patients undergoing renal transplantation. BMJ. 1972;63:574-584.
12. Winston DJ, Ho WG, Howell CL, et al. Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med. 1980;93:671-675.
13. Kaulfersch W, Urban C, Hauer C, et al. Successful treatment of CMV retinitis with ganciclovir after allogeneic marrow transplantation. Bone Marrow Transplant. 1989;4:587-589.
14. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis. 1990;12(suppl 7):S754-S766.
15. Winston DJ, Ho WG, Champlin RE. Cytomegalovirus infections after allogenic bone marrow transplantation. Rev Infect Dis. 1990;12(suppl 7):S776-S792.
16. Egbert PR, Pollard RB, Gallagher JG, Merigan TC. CMV retinitis in immunosuppressed hosts, II: ocular manifestations. Ann Intern Med. 1980;93:664-670.
17. Pollard RB, Egbert PR, Gallagher JG, Merigan TC. CMV retinitis in immunosuppressed hosts, I: natural history and effects of treatment with adenine arabinoside. Ann Intern Med. 1980;93:655-664.
18. Schuman JS, Orellana J, Friedman AH, Teich SA. Acquired immunodeficiency syndrome (AIDS). Surv Ophthalmol. 1987;31:384-410.
19. Palestine A. Clinical aspects of cytomegalovirus retinitis. Rev Infect Dis. 1988; 10(suppl 3):S515-S521.
20. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988;108:585-594.
21. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107:75-80.
22. Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ, the UCLA CMV Retinopathy Study Group. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinitis. Arch Ophthalmol. 1989;107:1759-1766.
23. Buhles WC Jr, Mastre BJ, Tinker AJ, Strand V, Koretz SH, the Syntex Collaborative Ganciclovir Treatment Study Group. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Rev Infect Dis. 1988;10(suppl 3):S495-S506.
24. Kuppermann BD, Flores-Aguilar M, Quieceno JI, Rickman LS, Freeman WR. Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol. 1993;111:1359-1366.
25. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med. 1992;326:213-220.
26. Walmsley SL, Chew E, Read SE, et al. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (foscarnet). J Infect Dis. 1988; 157:569-572.
27. Fanning MM, Read SE, Benson M, et al. Foscarnet therapy of cytomegalovirus retinitis in AIDS. J Acquit Immune Defic Syndr. 1990;3:472-479.
28. Holland GN, Sison RF, Jatulis DE, Haslop MG, Sakamoto MJ, Wheeler NC. Survival of patients with the acquired immune deficiency syndrome after the development of cytomegalovirus retinitis. Ophthalmology. 1990;97:204-211.
29. Luckie A, Ai E. Diagnosis and management of cytomegalovirus retinitis in AIDS. Curr Opin Ophthalmol. 1993;4:81-89.
30. Cox F, Hughes WT. Cytomegaloviremia in children with acute lymphocytic leukemia. J Pediatr. 1975;87:190-194.
31. Rosecan LR, Laskin OL, Kalman CM, Haik BG, Ellsworth RM. Antiviral therapy with ganciclovir for cytomegalovirus retinitis and bilateral exudative retinal detachments in an immunocompromised child. Ophthalmology. 1986;93:1404-1407.
32. Daus W, Zimmer KP, Moller P. Beidseitige Zytomegalie-Retinitis bei einem Saugling mit lethal verlaufenem konnatalen AIDS. Klin Monatsbl Augenheilkd. 1986;188: 604-609.
33. Levin AV, Zeichner S, Duker JS, Starr SE, Augsburger JJ, Kronwith S. Cytomegalovirus retinitis in an infant with acquired immunodeficiency syndrome. Pediatrics. 1989;84:683-687.
34. Dennehy PJ, Warman R, Flynn JT, Scott GB, Mastrucci MT. Ocular manifestations in pediatric patients with acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107:978-982.
35. Jonckheer T, de Selys A, Pierre C, et al. Retinite chez un nourrisson infecte par le VIH. Arch Fr Pediatr. 1990;47:585-586.
36. Frenkel LD, Gaur S, Tsolia M, Scudder R, Howell R, Kesarwala H. Cytomegalovirus infection in children with AIDS. Rev Infect Dis. 1990;12(suppl 7):S820-S825.
37. Butler KM, De Smet MD, Husson RN, et al. Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency syndrome. J Pediatr. 1992;120:483-486.
38. Salvador F, Blanco R, Colin A, Galan A, Gil-Gibernau JJ. Cytomegalovirus retinitis in pediatric acquired immunodeficiency syndrome: report of two cases. J Pediatr Ophthalmol Strabismus. 1993;30:159-162.
39. Walton RC, Whitcup SM, Mueller BU, Lewis LL, Pizzo PA, Nussenblatt RB. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis. Ophthalmology. 1995;102:1865-1870.
40. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Rapid detection of cytomegalovirus in MRC-5 cells innoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J Clin Microbiol. 1984;19:917-919.
41. Beckwith DG, Halstead DC, Alpaugh K, Schweder A, Blount-Fronefield DA, Toth K. Comparison of a latex agglutination test with five other methods for determining the presence of antibody against cytomegalovirus. J Clin Microbiol. 1985;21:328-331.
42. Computing Resource Center. Stata Reference Manual: Release 3.0. 5th ed. Santa Monica, Calif;1992;2:240-273.
43. Istas AS, Demmler GJ, Dobbins JG, Stewart JA, the National Congenital Cytomegalovirus Disease Registry Collaborating Group. Surveillance for cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis. 1995;20:665-670.
44. Boppana S, Amos C, Britt W, Stagno S, Alford C, Pass R. Late onset and reactivation of chorioretinitis in children with congenital cytomegalovirus infection. Pediatr Infect Dis J. 1994;13:1139-1142.
45. Dummer JS. Cytomegalovirus infection after liver transplantation: clinical manifestations and strategies for prevention. Rev Infect Dis. 1990;12(suppl 7): S767-S775.
46. Kusne S, Dummer JS, Sing N, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine. 1988;67:132-143.
47. Rakela J, Wiesner RH, Taswell HF, et al. Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. Transplant Proc. 1987;19:2399-2402.
48. Singh N, Dummer JS, Kusne S, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis. 1988;158:124-131.
49. Snydman D. Ganciclovir therapy for cytomegalovirus disease associated with renal transplants. Rev Infect Dis. 1988;10(suppl 3):S554-S562.
50. Keay S, Petersen E, Icenogle T, et al. Ganciclovir treatment for serious cytomegalovirus infection in heart and heart-lung transplant recipients. Rev Infect Dis. 1988;10(suppl 3):S563-S546.
51. Winston DJ, Ho WG, Bartoni K, et al. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients. Rev Infect Dis. 1988;10(suppl 3):S547-S552.
52. Coskuncan NM, Jabs DA, Dunn JP, et al. The eye in bone marrow transplantation. Arch Ophthalmol. 1994;112:372-379.
53. Wingard JR, Piantadosi S, Burns WH, Zahurak MI, Santos GW, Saral R. Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy. Rev Infect Dis. 1990;12(suppl 7):S793-S804.
54. Meyers JD, Ljungman P, Fisher LD. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis. 1990;162:373-380.
55. Goodrich JM, Mori M, Gleaves CA, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med. 1991;325:1601-1607.
56. Cox F, Meyer D, Hughes WT. Cytomegalovirus in tears from patients with normal eyes and with acute cytomegalovirus chorioretinitis. Am J Ophthalmol. 1975;80:817-824.
57. The TH, van der Ploeg M, van den Berg AP, Vlieger AM, van der Giessen M, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes: a review of the antigenemia assay and the polymerase chain reaction. Transplantation. 1992;54:193-198.
58. Chou S. Newer methods for diagnosis of cytomegalovirus infection. Rev Infect Dis. 1990;12(suppl 7):S727-S736.
59. Demmler G, Buffone GJ, Schimbor CM, May RA. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis. 1988;158:1177-1184.
60. Shibata D, Martin WJ, Appleman MD, Causey DM, Leedom JM, Arnheim N. Detection of cytomegalovirus in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis. 1988;158:1185-1192.
61. Shen CY, Chang W, Chang S, Huang E, Wu CW. Cytomegalovirus transmission in special-care centers for mentally retarded children. Pediatrics. 1993; 91:79-82.
62. Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. J Clin Microbiol. 1993;31:2851-2856.
63. Locatelli F, Percivalle E, Comoli P, et al. Human cytomegalovirus (HCMV) infection in paediatric patients given allogenic bone marrow transplantation: role of early antiviral treatment for HCMV antigenemia on patient outcome. Br J Haematol. 1994;88:64-71.
64. Nolte FS, Emmens RK, Thurmond C, et al. Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplification. J Clin Microbiol. 1995;33:1263-1266.